15 Biggest Mid-Day Losers For Wednesday

 

  • XOMA Corp XOMA shares fell 18.3 percent to $5.10 after the company disclosed a significant step toward initiating pediatric Phase 2 clinical study for XOMA 358 in children with congenital hyperinsulinism.
  • Puma Biotechnology Inc PBYI dropped 15.4 percent to $44.55 after the company announced a $150 million offering of common stock.
  • Imperva Inc IMPV shares fell 14.4 percent to $39.95 after concerns were raised on the possible sale. According to a Bloomberg report, the sale process has been put on a hold, as the company is seeking increased deal price.
  • VASCO Data Security International, Inc. VDSI shares tumbled 14 percent to $15.43 as the company lowered its FY16 revenue guidance. Dougherty & Co. downgraded VASCO Data Security from Buy to Neutral.
  • Acadia Healthcare Company Inc ACHC shares fell 11.4 percent to $40.04 after the company reported the signing of definitive deal for sale of UK facilities in fulfillment of previously announced undertakings to the CMA. The company issued a weak forecast for the third quarter.
  • WSI Industries, Inc. WSCI shares slipped 11.3 percent to $3.27. WSI Industries reported a Q4 loss of $0.01 per share on sales of $8.1 million.
  • Cree, Inc. CREE shares declined 10.8 percent to $22.48 after the company issued a weak earnings forecast for the fiscal second quarter.
  • UniFirst Corp UNF fell 10 percent to $117.80. Unifirst reported Q4 earnings of $1.74 per share on revenue of $363 million.
  • Manhattan Associates, Inc. MANH declined 8.6 percent to $53.94. Manhattan Associates reported Q3 earnings of $0.50 per share on revenue of $152.2 million. The company also raised its FY16 earnings guidance.
  • Sangamo Biosciences, Inc. SGMO shares dropped 8.5 percent to $3.57 after gaining 1.30 percent on Tuesday.
  • SUPERVALU INC. SVU shares declined 8.3 percent to $4.61. SUPERVALU reported in-line quarterly earnings, but missed sales estimates.
  • Intel Corporation INTC shares slipped 5.8 percent to $35.57. Intel reported better-than-expected earnings for its third quarter, but issued a weak revenue forecast for the current quarter.
  • Meridian Bioscience, Inc. VIVO shares fell 5.6 percent to $17.60 after the company issued a weak outlook.
  • Nektar Therapeutics NKTR shares declined 5 percent to $13.36 after dropping 10.15 percent on Tuesday.
  • Ascendis Pharma A/S ASND shares slipped 3.7 percent to $19.34. Ascendis Pharma priced its 6.3 million share offering at $19 per ADS.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsMovers & ShakersIntraday UpdateMarketsApplication SoftwareInformation TechnologyMid-Day LosersTop Losers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!